Sons Minoxidil 5% Cutaneous Solution is for the treatment of moderate male-pattern hair loss in adult males. This item is suitable for Adult Males Minoxidil solution increases blood flow and oxygen in vessels which reactivates and revitalises shrunken hair follicles that have been shrunken by DHT. DHT is a by-product of the male hormone testosterone - if you have a sensitivity to this hormone, it attaches to your hair follicles and causes the tea. Minoxidil is suitable for men with mild hair loss that are experiencing the early signs of a receding hairline and hair loss in the crown area. How long until I see results? Whilst Minoxidil begins working immediately, results take around 3 months to become visible and a further 9 months to reach their peak. It’s important to note that some men will experience initial shedding when they first start using this solution, and whilst this can be concerning, this is actually a sign that the medication is working. Minoxidil improves blood flow to the scalp which can trigger your old hair to shed, but this should be replaced with stronger, healthier hair after 9-12 months of consistent use. Why should I use this treatment? You should use this treatment if you want a scientifically-backed solution to treat mild to moderate hair loss. Minoxidil is one of only two medications that is approved by the FDA as being effective at treating male pattern hair loss. How to use Please read the enclosed leaflet carefully before use.Patient Information Leaflets are updated periodically by the manufacturer.For cutaneous use.Do not ingest. It should only be applied directly to the scalp area. Directions For adult men aged 18-65 years. The recommended dose is 1ml of solution every 12 hours (1ml is equivalent to 10 metered sprays). The hair and scalp must be completely dry when applying the product.. Spread the solution using your fingertips on the treatment area, starting from the centre. To be applied to the hair only. For external use only. Read the package leaflet before use. As with all medicines, please ensure you read the patient information leaflet before taking this item.
Related
Related
Related
Related